{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:33:23Z","timestamp":1770824003470,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"vor","delay-in-days":3152,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To ascertain whether anti\u2010D immunoglobulin is being administered to Rhesus D negative women in accordance with the 1991 recommendations for its use to cover all events which may result in fetomaternal haemorrhage.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> The notes of women delivered in 1994 were examined for compliance with the 1991 recommendations.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Seven maternity units using a central antenatal screening service.<\/jats:p><jats:p><jats:bold>Participants\n\t\t\t\t\t<\/jats:bold> Nine hundred and twenty\u2010two Rhesus D negative women delivered in these seven hospitals.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> The prescription, dosage and indications for administration of anti\u2010D immunoglobulin to women during pregnancy and in the puerperium.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Postnatal anti\u2010D immunoglobulin was given in appropriate doses to more than 95% of women who required it. Omissions mainly arose from confusion among women who recently had received antenatal treatment with anti\u2010D immunoglobulin. The 1991 recommendations for antenatal administration were less closely followed. Abdominal trauma was covered in only 20% of cases. An inadequate dosage of 250 IU was given to 25 women for antepartum haemorrhage after 20 weeks of gestation. The purpose of the Kleihauer test was sometimes poorly understood, with a \u2018negative\u2019 result interpreted as a reason not to give anti\u2010D immunoglobulin.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> Closer adherence to the 1991 recommendations might further reduce the incidence of Rhesus D immunisation below the current 1%. It is suggested that more careful application of the recommendations should be evaluated before considering either routine antenatal prophylaxis, or the European recommendation of a larger dose (1000\u20131500 IU), both of which would increase the requirements for this limited resource.<\/jats:p>","DOI":"10.1111\/j.1471-0528.1997.tb10646.x","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T09:24:51Z","timestamp":1124443491000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Preventing Rhesus D haemolytic disease of the newborn by giving anti\u2010D immunoglobulin: are the guidelines being adequately followed?"],"prefix":"10.1111","volume":"104","author":[{"given":"Helen L.","family":"Howard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa J.","family":"Martlew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain R.","family":"McFadyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"e_1_2_5_2_2","volume-title":"Blood Transfusion in Clinical Medicine","author":"Mollison PL","year":"1993"},{"key":"e_1_2_5_3_2","unstructured":"Prevention of Rh sensitisation: report of WHO Scientific group. WHO Technical Report Series 468 1971."},{"key":"e_1_2_5_4_2","volume-title":"Haemolytic Disease of the Newborn","author":"Standing Medical Advisory Committee","year":"1976"},{"key":"e_1_2_5_5_2","volume-title":"SMAC Memorandum on Haemolytic Disease of the Newborn\u20141976: Addendum\u20141981","author":"Standing Medical Advisory Committee","year":"1982"},{"key":"e_1_2_5_6_2","first-page":"310","article-title":"Decline in deaths from Rhesus haemolytic disease of the newborn","volume":"28","author":"Clarke CA","year":"1994","journal-title":"JR Colt Physicians Land."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1992.tb00142.x"},{"key":"e_1_2_5_8_2","volume-title":"Note for guidance: Core Summary of Product Characteristics of Human Anti\u2010D Immunoglobulin","author":"Committee for Proprietary Medicinal Products","year":"1992"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6689.1671"},{"key":"e_1_2_5_10_2","first-page":"51","volume-title":"Guidelines for the Blood Transfusion Service UKBTS\/NIBSC","author":"Immunisation of donors","year":"1994"},{"key":"e_1_2_5_11_2","first-page":"137","article-title":"recommendations for the use of anti\u2010D immunoglobulin","volume":"31","author":"NBTS Immunoglobulin Working Party","year":"1991","journal-title":"Prescribers Journal"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1996.d01-518.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5910.75"},{"key":"e_1_2_5_14_2","first-page":"806","article-title":"Hughes RH, Craig JIO, Greer IA. Many cases of sensitisation may be avoidable [letter]","volume":"309","author":"Murphy WG","year":"1994","journal-title":"BMJ"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb13613.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6949.240"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.1997.tb10646.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.1997.tb10646.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T20:57:50Z","timestamp":1698440270000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.1997.tb10646.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1111\/j.1471-0528.1997.tb10646.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.1997.tb10646.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]},"assertion":[{"value":"2005-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}